[Measurement of the secretion of growth hormone in patients with thalassemia major]. 1993

G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
Cattedra di Fisiopatologia Endocrina, Centro Sanitario, Università degli Studi della Calabria, Cosenza.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008297 Male Males
D011627 Puberty A period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction (FERTILITY), development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT. Puberties
D011729 Pyridostigmine Bromide A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. Mestinon,Pyridostigmine,Bromide, Pyridostigmine
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D004392 Dwarfism A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height. Nanism
D005260 Female Females

Related Publications

G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
January 1990, Acta paediatrica Scandinavica,
G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
March 1995, Minerva pediatrica,
G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
October 2006, Archives of Iranian medicine,
G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
April 2005, Journal of endocrinological investigation,
G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
December 1999, Pediatrics international : official journal of the Japan Pediatric Society,
G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
February 2000, Journal of pediatric endocrinology & metabolism : JPEM,
G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
January 1998, Journal of pediatric endocrinology & metabolism : JPEM,
G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
August 2004, European journal of endocrinology,
G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
January 1990, Acta paediatrica Scandinavica. Supplement,
G De Luca, and M Maggiolini, and M Bria, and M Caracciolo, and M Lanzino, and M Le Pera, and C Brancati, and S Andò
October 2007, Hematology (Amsterdam, Netherlands),
Copied contents to your clipboard!